We are delighted to announce that PharmEnable has been awarded Rising Star in the DeepTech Investment of the Year category at the UKBAA Angel Investment Awards 2021.
The annual UKBAA Angel Investment awards, sponsored by Playfair Capital, recognise acknowledge the high growth of early-stage teams – celebrating the fastest growing brands and the founders, angels and early-stage venture capital investors behind them.
PharmEnable’s CEO, Dr Hannah Sore, said: “PharmEnable has a fantastic group of investors and angels that understand our vision and believe in the potential of AI to change the drug discovery landscape. We are excited to receive the Rising Star award and delighted that the excellent work of our team, investors and angels has been recognised, as they support our mission to unlock innovative medicines.”
The award celebrates the investors and founders that are pioneering deep technologies, such as AI and machine learning, to achieve fundamental breakthroughs to global challenges.
